<?xml version="1.0" encoding="UTF-8"?>
<rss 
    xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" 
    xmlns:atom="http://www.w3.org/2005/Atom" 
    version="2.0">
    <channel>
        <title>Applied Clinical Trials Podcast</title>
        <description>Get the latest information from Applied Clinical Trials delivered straight to your iPod or favorite MP3 listening device.</description>
        <link>http://act.scpodcasts.com/home.htm</link>
        <copyright>Copyright 2008 Advanstar Communications</copyright>
        <language>en-us</language>
        <lastBuildDate>Mon, 10 Aug 2009 11:24:35 -0700</lastBuildDate>
        <managingEditor>webmaster@scpodcasts.com (Webmaster)</managingEditor>
        <pubDate>Mon, 10 Aug 2009 06:49:26 -0700</pubDate>
        <generator>FeedForAll v2.0 (2.0.2.9) http://www.feedforall.com</generator>
        <itunes:subtitle>Applied Clinical Trials Podcast</itunes:subtitle>
        <itunes:summary>Applied Clinical Trials Podcast</itunes:summary>
        <itunes:author>Advanstar Communications</itunes:author>
        <itunes:owner>
            <itunes:name>Advanstar Communications</itunes:name>
            <itunes:email>webmaster@scpodcasts.com</itunes:email>
        </itunes:owner>
        <itunes:category text="Science &amp; Medicine">
            <itunes:category text="Medicine"/>
        </itunes:category>
        <itunes:keywords>Medical, Clinical</itunes:keywords>
        <itunes:image href="http://act.scpodcasts.com/images/albumcover.jpg"/>
        <itunes:explicit>no</itunes:explicit>
        <itunes:block>no</itunes:block>
        <atom:link href="http://act.scpodcasts.com/actrss.xml" rel="self" type="application/rss+xml"/>
        <image>
            <url>http://act.scpodcasts.com/images/podlogo.jpg</url>
            <title>Applied Clinical Trials Podcast</title>
            <link>http://act.scpodcasts.com/home.htm</link>
            <width>144</width>
            <height>144</height>
        </image>
        <item>
            <title>Behind-the-Scenes with Regulatory Affairs</title>
            <description>How has the role of Regulatory Affairs evolved? Armed with results from a Tufts CSDD 2008/2009 study, Kenneth Getz, MBA, explains how, providing a vivid analysis of the expectations, responsibilities, and required skills of today´s Regulatory Affairs professional.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/dia-rs-01.mp3" length="5168300" type="audio/mpeg"/>
            <guid isPermaLink="false">145C852A-FF44-448D-9313-0C3A25C9E8FC</guid>
            <pubDate>Mon, 1 Jun 2009 11:11:29 -0700</pubDate>
            <itunes:subtitle>Behind-the-Scenes with Regulatory Affairs</itunes:subtitle>
            <itunes:summary>How has the role of Regulatory Affairs evolved? Armed with results from a Tufts CSDD 2008/2009 study, Kenneth Getz, MBA, explains how, providing a vivid analysis of the expectations, responsibilities, and required skills of today´s Regulatory Affairs professional.</itunes:summary>
            <itunes:duration>10:42</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>Rewards for Subjects, an Ethical Dilemma?</title>
            <description>Felix Gyi, PharmD, MBA, CEO of Chesapeake Research Review discusses ethical rewards for patients in clinical studies and how the relationships between pharma and health care professionals affects subject recruitment and retention.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/dia-rs-02.mp3" length="2928300" type="audio/mpeg"/>
            <guid isPermaLink="false">796CE917-9736-40B3-B9AC-1AFCC7339385</guid>
            <pubDate>Mon, 1 Jun 2009 11:07:30 -0700</pubDate>
            <itunes:subtitle>Rewards for Subjects, an Ethical Dilemma?</itunes:subtitle>
            <itunes:summary>Felix Gyi, PharmD, MBA, CEO of Chesapeake Research Review discusses ethical rewards for patients in clinical studies and how the relationships between pharma and health care professionals affects subject recruitment and retention.</itunes:summary>
            <itunes:duration>6:02</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>Meet DIA&apos;s Program Chair</title>
            <description>Nancy D. Smith, PhD, former director, office of training and communications, CDER, FDA, discusses this year&apos;s meeting theme, &quot;Better Medicines: Improving Safety with Every Step,&quot; and the CDER Town Meeting that has become a DIA staple</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/dia-rs-03.mp3" length="3458000" type="audio/mpeg"/>
            <guid isPermaLink="false">B9E2F926-FC6F-404E-B198-6FBA4B171871</guid>
            <pubDate>Mon, 1 Jun 2009 11:04:04 -0700</pubDate>
            <itunes:subtitle>Meet DIA&apos;s Program Chair</itunes:subtitle>
            <itunes:summary>Nancy D. Smith, PhD, former director, office of training and communications, CDER, FDA, discusses this year&apos;s meeting theme, &quot;Better Medicines: Improving Safety with Every Step,&quot; and the CDER Town Meeting that has become a DIA staple.</itunes:summary>
            <itunes:duration>7:08</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>eCTD: In-house eCTD vs. Off-the-Shelf Software</title>
            <description>Valerie Mackner of Wyeth Pharmaceuticals discusses moving from in-house eCTD software to an off-the-shelf product.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/mackner-rs.mp3" length="1117500" type="audio/mpeg"/>
            <guid isPermaLink="false">653A32AB-CE8D-4A1A-BFEB-CA3C0C5FF509</guid>
            <pubDate>Wed, 1 Apr 2009 11:19:30 -0700</pubDate>
            <itunes:subtitle>eCTD: In-house eCTD vs. Off-the-Shelf Software</itunes:subtitle>
            <itunes:summary>Valerie Mackner of Wyeth Pharmaceuticals discusses moving from in-house eCTD software to an off-the-shelf product.</itunes:summary>
            <itunes:duration>2:15</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>eCTD: Pilot Testing eCTD Software</title>
            <description>Veteran regulatory affairs professional Dr. Albert Edwards, PharmD, RAC, Director, Regulatory Operations, Takeda offers his views for eCTD implementation in the future</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/edwards-rs.mp3" length="1138300" type="audio/mpeg"/>
            <guid isPermaLink="false">B40117EB-7488-481E-A8EF-4B35B3F8EE19</guid>
            <pubDate>Wed, 1 Apr 2009 10:34:11 -0700</pubDate>
            <itunes:subtitle>eCTD: Pilot Testing eCTD Software</itunes:subtitle>
            <itunes:summary>Veteran regulatory affairs professional Dr. Albert Edwards, PharmD, RAC, Director, Regulatory Operations, Takeda offers his views for eCTD implementation in the future</itunes:summary>
            <itunes:duration>2:18</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>eCTD: Training Employees on eCTD</title>
            <description>Shire Pharmaceuticals’ Carol Rutkowski, Senior Director, Global Regulatory Operations, Shire explains the benefits of training employees in regard to the regulatory eCTD submissions world.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/rutkowski-rs.mp3" length="1964000" type="audio/mpeg"/>
            <guid isPermaLink="false">19DC98C5-5A1D-4B02-ACFF-C1467A89B1C8</guid>
            <pubDate>Wed, 1 Apr 2009 10:31:07 -0700</pubDate>
            <itunes:subtitle>eCTD: Training Employees on eCTD</itunes:subtitle>
            <itunes:summary>Shire Pharmaceuticals’ Carol Rutkowski, Senior Director, Global Regulatory Operations, Shire explains the benefits of training employees in regard to the regulatory eCTD submissions world.</itunes:summary>
            <itunes:duration>4:01</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>eCTD: Bringing in an Objective Outsider</title>
            <description>Michael J. McGraw, PharmD, MS, regulatory affairs manager at Teva Neuroscience, discusses the benefits of bringing in an objective outsider.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/mcgraw-rs.mp3" length="1254100" type="audio/mpeg"/>
            <guid isPermaLink="false">77698462-46B3-47CE-B1E6-AC1CFE560810</guid>
            <pubDate>Wed, 1 Apr 2009 06:58:04 -0700</pubDate>
            <itunes:subtitle>eCTD: Bringing in an Objective Outsider</itunes:subtitle>
            <itunes:summary>Michael J. McGraw, PharmD, MS, regulatory affairs manager at Teva Neuroscience, discusses the benefits of bringing in an objective outsider.</itunes:summary>
            <itunes:duration>2:48</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>eCTD: Challenges to eCTD</title>
            <description>Janel Firestein,(Associate Partner, Clarkston Consulting) our roundtable moderator, offers her take on the expert discussion and the major challenge she sees to eCTD implementation.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/firestein-rs.mp3" length="1378300" type="audio/mpeg"/>
            <guid isPermaLink="false">ACT-09-17</guid>
            <pubDate>Wed, 1 Apr 2009 06:49:20 -0700</pubDate>
            <itunes:subtitle>eCTD: Challenges to eCTD</itunes:subtitle>
            <itunes:summary>Janel Firestein,(Associate Partner, Clarkston Consulting) our roundtable moderator, offers her take on the expert discussion and the major challenge she sees to eCTD implementation.</itunes:summary>
            <itunes:duration>2:48</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>eCTD: Moving from Paper to Electronic Submissions</title>
            <description>Laurie Henricks (Senior Director, Global Regulatory Affairs and Medical Writing, Quintiles) tells us how--in her CRO capacity--she coaches sponsor/clients to get more comfortable with moving from paper submissions to electronic submissions.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/henricks-rs.mp3" length="2048200" type="audio/mpeg"/>
            <guid isPermaLink="false">ACT-09-16</guid>
            <pubDate>Wed, 1 Apr 2009 09:17:42 -0700</pubDate>
            <itunes:subtitle>eCTD: Moving from Paper to Electronic Submissions</itunes:subtitle>
            <itunes:summary>Laurie Henricks (Senior Director, Global Regulatory Affairs and Medical Writing, Quintiles) tells us how--in her CRO capacity--she coaches sponsor/clients to get more comfortable with moving from paper submissions to electronic submissions.</itunes:summary>
            <itunes:duration>4:12</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>Ins &amp; Outs of Comparator Drug Sourcing</title>
            <description>Mark Ware, Director, Clinical Trial Services at IDIS, explains how procurement teams charged with sourcing comparator drugs for clinical trials can move from a tactical sourcing approach to a strategic approach.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/idis-rs-02.mp3" length="8059400" type="audio/mpeg"/>
            <guid isPermaLink="false">ACT-09-15</guid>
            <pubDate>Wed, 1 Apr 2009 09:13:47 -0700</pubDate>
            <itunes:subtitle>Ins &amp; Outs of Comparator Drug Sourcing</itunes:subtitle>
            <itunes:summary>Mark Ware, Director, Clinical Trial Services at IDIS, explains how procurement teams charged with sourcing comparator drugs for clinical trials can move from a tactical sourcing approach to a strategic approach.</itunes:summary>
            <itunes:duration>16:43</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
        <item>
            <title>Global Trial Considerations</title>
            <description>Viq Pervaaz, VP, Global Project Management MDS Pharma Services, speaks to Applied Clinical Trials Editor in Chief Lisa Henderson about the challenges associated with clinical trials in China. Pervaaz highlights specimen management, regional requirements and other insights he will share at the Partnerships with CROs and Clinical Providers conference in Orlando later this month.</description>
            <link>http://appliedclinicaltrialsonline.findpharma.com/podcasts</link>
            <enclosure url="http://act.scpodcasts.com/podcasts/mdspharma-rs-01.mp3" length="8037000" type="audio/mpeg"/>
            <guid isPermaLink="false">ACT-09-14</guid>
            <pubDate>Wed, 1 Apr 2009 09:03:05 -0700</pubDate>
            <itunes:subtitle>Global Trial Considerations</itunes:subtitle>
            <itunes:summary>Viq Pervaaz, VP, Global Project Management MDS Pharma Services, speaks to Applied Clinical Trials Editor in Chief Lisa Henderson about the challenges associated with clinical trials in China. Pervaaz highlights specimen management, regional requirements and other insights he will share at the Partnerships with CROs and Clinical Providers conference in Orlando later this month.</itunes:summary>
            <itunes:duration>16:40</itunes:duration>
            <itunes:author>Applied Clinical Trials Magazine</itunes:author>
            <itunes:keywords>Clinical Trials, Medicine</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        </item>
    </channel>
</rss>
